Search results
TauRx Submits UK Marketing Authorisation Application for HMTM as a Treatment for Alzheimer's Disease
Financial Post· 4 days agoAuthorisation Application (MAA) for hydromethylthionine mesylate (HMTM) for treatment of mild cognitive impairment (MCI-AD) and mild to moderate stages of